AVR 2.32% $12.20 anteris technologies ltd

Ann: Key Animal Study for EFS Submission Completed, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 303 Posts.
    lightbulb Created with Sketch. 113
    this is great that we finally have some news. timeline is a concern for options.
    will people pop on just the results of the study or will they wait for official FDA approval.
    4 more weeks for official results puts us into November.
    Do we need to compile all of this to submit and take more time or do we submit as we go?
    How quickly can our EFS be approved from this point?
    It's Exciting times though, hope there's more news flow to support this
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.